Wednesday, December 14, 2016

Just Some House-Keeping Notes: Upcoming Scheduled Hearings, For Merck Vs. Ono/BMS (Pembrolizumab Vs. Nivolumab) Patent Spats -- In Delaware

As I head out -- a little early, this evening -- to reach various client holiday gatherings, I'll just offer the latest oral order in this matter, as well as the related case's scheduling amendments -- as filed in the last few days, for those of you keeping score at home. [If the parties don't settle, this set of cases won't go to trial until some time in early 2019, in my estimation.]

Here's the bit -- and the longer order, from the other (not Delaware; New Jersey) federal District court patent case (an 11 page PDF file):

. . . .ORAL ORDER:

The teleconference with Judge Thynge set for 12/12/16 at 10:00 AM Eastern Time has been rescheduled to 1/17/17 at 10:00 AM Eastern Time. Plaintiffs' counsel to initiate the teleconference call.

Ordered by Judge Mary Pat Thynge on 12/8/16. Associated Cases: 1:14-cv-01131-GMS, 1:15-cv-00560-GMS, 1:15-cv-00572-GMS. . . .

Now you know. And onward -- into the frigid, but clear night-air.


No comments: